Scientists trace experimental Drug's journey through the body
NCT ID NCT07219017
Summary
This study aimed to understand how the body processes and eliminates an experimental drug called ABBV-1354 (Icalcaprant). Eight healthy adult men received a single oral dose containing a tiny, safe amount of radioactive carbon to help track the drug. Researchers measured how much drug was absorbed, how long it stayed in the body, and how it was removed through urine and feces, while also checking for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit Inc /ID# 277011
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.